Converting a tumor from checkpoint blockade-resistant to checkpoint blockade-sensitive: Immunotransplant for aggressive lymphoma.

被引：0
|
作者：
Marshall, Netonia
Hammerich, Linda
Upadhyay, Ranjan
Marron, Thomas Urban
Brody, Joshua
机构：
[1] Mt Sinai Hosp, Ichan Med Sch, New York, NY USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
[3] Mt Sinai Hosp, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e14538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14538
引用
收藏
页数：2
相关论文
共 39 条
  • [1] Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects
    Modur, Vishnu
    Muhammad, Belal
    Yang, Jun-Qi
    Zheng, Yi
    Komurov, Kakajan
    Guo, Fukun
    CELL REPORTS, 2023, 42 (04):
  • [2] Tumor-specific T cells reprogram mononuclear phagocytes for destruction of checkpoint blockade-resistant pancreatic cancer
    Dougan, Stephanie K.
    CANCER RESEARCH, 2019, 79 (24)
  • [3] Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma
    Carbone, Antonino
    Gloghini, Annunziata
    Carlo-Stella, Carmelo
    BLOOD, 2023, 141 (18) : 2187 - 2193
  • [4] Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge
    van der Westhuizen, Andre
    Lyle, Megan
    Graves, Moira C.
    Zhu, Xiaoqiang
    Wong, Jason W. H.
    Cornall, Kerrie
    Ren, Shu
    Pugliese, Leanna
    Levy, Richard
    Majid, Adeeb
    Vilain, Ricardo E.
    Bowden, Nikola A.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (08): : 814 - 826
  • [5] Immune checkpoint blockade in glioblastoma from tumor heterogeneity to personalized treatment
    Arrieta, Victor A.
    Dmello, Crismita
    McGrail, Daniel J.
    Brat, Daniel J.
    Lee-Chang, Catalina
    Heimberger, Amy B.
    Chand, Dhan
    Stupp, Roger
    Sonabend, Adam M.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (02):
  • [6] Phosphatidylserine targeting and radiation improves survival in a mouse tumor model resistant to checkpoint blockade
    Giese, Rachel
    Budhu, Sadna
    Barker, Christopher
    Gupta, Aditi
    King, Steve
    Shan, Joseph
    Wolchok, Jedd
    Merghoub, Taha
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy
    Carreau, Nicole A.
    Pail, Orrin
    Armand, Philippe
    Merryman, Reid W.
    Advani, Ranjana H.
    Spinner, Michael A.
    Herrera, Alex F.
    Chen, Robert W.
    Tomassetti, Sarah
    Ramchandren, Radhakrishnan
    Hamid, Muhammad
    Assouline, Sarit
    Santiago, Raoul
    Wagner-Johnston, Nina D.
    Paul, Suman
    Svoboda, Jakub
    Bair, Steven M.
    Barta, Stefan Klaus
    Liu, Yang
    Nathan, Sunita
    Burkart, Madelyn
    Karmali, Reem
    Torka, Pallawi
    David, Kevin A.
    Wei, Catherine
    Lansigan, Frederick
    Emery, Lukas
    Persky, Daniel
    Smith, Sonali M.
    Chavez, Julio C.
    Xia, Yuhe
    Troxel, Andrea B.
    Diefenbach, Catherine
    BLOOD, 2018, 132
  • [8] Tumor cell-derived lactic acid inhibit anti-tumor immunity in the immune checkpoint blockade resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Sun, Ruoxuan
    Lim, Seung-Oe
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [9] Identification of Tigit on Intra-Tumor T Cells As a New Target for Immune Checkpoint Blockade in Follicular Lymphoma
    Gothberg, Sarah
    Huse, Kanutte
    Kolstad, Arne
    Lingjaerde, Ole Christian
    Ostenstad, Bjorn
    Smeland, Erlend
    Levy, Ronald
    Irish, Jonathan Michael
    Myklebust, June Helen
    BLOOD, 2016, 128 (22)
  • [10] Combined epigenetic therapy and immune checkpoint blockade drive reshaping of the tumor microenvironment of platinum resistant ovarian cancer
    Landon, Blair V.
    Kaleka, Guneet
    Balan, Archana
    Boland, Julia L.
    Cherry, Christopher
    Pereira, Gavin
    Zahnow, Cynthia
    Winterhoff, Boris
    Baylin, Stephen
    Velculescu, Victor E.
    Konecny, Gottfried E.
    Glaspy, John A.
    Anagnostou, Valsamo
    CANCER RESEARCH, 2024, 84 (06)
1234